Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2010
05/11/2010US7714121 Protein for vaccines; immunology response; medical diagnosis; antibody binding to protein
05/11/2010US7714111 Antibodies specific for myostatins; reduced turbidity, impurities
05/11/2010US7714109 antibody, immunoconjugate and duramycin-based compositions; bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases
05/11/2010US7714108 Mammalian tumor susceptibility gene products and their uses
05/11/2010US7713995 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
05/11/2010US7713942 Drug delivery able crossing cellular membranes; transdermal, electrostatic interaction and a hydrophobic interaction
05/11/2010US7713915 cloning; ribosome inactivating protein
05/11/2010US7713714 Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof
05/11/2010US7713712 immunizing an animal with a mixture of different histidine fusion polypeptides and obtaining polyclonal antibodies directed against the histidine portion of the fusion polypeptides from the serum of the animal; rapid
05/11/2010US7713710 Isolation and use of solid tumor stem cells
05/11/2010US7713535 Respiratory disorders, inflammatory disorders, allergy, or asthma
05/11/2010US7713534 Streptococcus pneumoniae proteins and nucleic acid molecules
05/11/2010US7713531 Protein, a gene encoding therefor and a method of using the same
05/11/2010US7713530 HIV-1 subtype isolate regulatory/accessory genes, and modification and derivatives thereof
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010US7713528 Method for in vivo delivery of active compounds using reagent conjugate
05/11/2010US7713527 Specific avian egg antibodies for disease prevention and improvement of growth performance
05/11/2010US7713526 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
05/11/2010US7713525 Biomarkers for cancer sensitivity and uses thereof
05/11/2010US7713524 treating hemolytic disease of the newborn, Sezary Syndrome, chronic myeloid leukemias, chronic lymphoid leukemias (CLL-B), cancer, breast cancer, conditions related to the environment, infectious diseases, chronic fatigue syndrome (CFS), parasitic infections, or viral infections
05/11/2010CA2527225C Modified recombinant vaccinia viruses and other microorganisms, uses thereof
05/11/2010CA2455134C Adjuvants for use in vaccines
05/11/2010CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
05/11/2010CA2279517C Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
05/11/2010CA2223261C Improved delivery of diagnostic and therapeutic agents to a target site
05/11/2010CA2184493C Methods and compositions useful for inhibition of angiogenesis
05/11/2010CA2180965C Influenza vaccine
05/11/2010CA2165401C Immunogenic hybrid protein oprf-oprl derived from pseudomonas aeruginosa membrane proteins
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/08/2010CA2738644A1 Hepatitis c antibodies and uses thereof
05/06/2010WO2010051502A2 Light targeting molecules and uses thereof
05/06/2010WO2010051391A1 Use of anti-cs1 antibodies for treatment of rare lymphomas
05/06/2010WO2010051307A1 Methods for mediating fibrotic response
05/06/2010WO2010051215A1 Methods for making hiv vaccines and related compositions
05/06/2010WO2010051210A1 Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
05/06/2010WO2010051105A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
05/06/2010WO2010051056A2 ANTI-FcεRI POLYPEPTIDES AND THEIR USES
05/06/2010WO2010051039A1 Compositions of activated botulinum toxin type b
05/06/2010WO2010050916A1 Estrogen receptor ligand treatment for neurodegenerative diseases
05/06/2010WO2010050913A1 Vaccination with poxvirus vectors via mechanical epidermal disruption
05/06/2010WO2010050903A1 Chimeric flagellins for vaccines
05/06/2010WO2010050902A1 Vaccines, which combine the antigen and toll-like receptors
05/06/2010WO2010050585A1 Vector for treating alzheimer's disease
05/06/2010WO2010050584A1 Method for selectively controlling function of helper t cell
05/06/2010WO2010050578A1 Mucosal vaccine using cationic nanogel
05/06/2010WO2010050528A1 Anti-muc1 antibody
05/06/2010WO2010050268A1 Molecular marker for cancer stem cell
05/06/2010WO2010050190A1 Molecular marker for cancer stem cell
05/06/2010WO2010050181A1 Vaccine for preventing onset and recurrence of liver cancer induced by hepatitis c virus
05/06/2010WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
05/06/2010WO2010049935A1 Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
05/06/2010WO2010049806A1 Purification method
05/06/2010WO2010049375A1 Use of bacteria for the sensing and killing of cancer cells
05/06/2010WO2010030182A3 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
05/06/2010WO2010030167A3 Method of detection and diagnosis of oral and nasopharyngeal cancers
05/06/2010WO2010029497A8 Treatment of endometriosis
05/06/2010WO2010021729A3 Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling
05/06/2010WO2010014751A3 Monoclonal antibody zt/2f2 in targeted therapy of cancers overexpressing the ron receptor tyrosine kinase
05/06/2010WO2010009129A3 Methods of treating autoimmune diseases using cd4 antibodies
05/06/2010WO2010008554A3 Methods and products for treating proliferative diseases
05/06/2010WO2010006326A3 Methods and compositions for spore-based vaccines
05/06/2010WO2010006136A3 Adenovirus targeting
05/06/2010WO2010005513A3 Crystal structure of staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof
05/06/2010WO2009144088A3 Vaccine for protection against lawsonia intracellulars
05/06/2010WO2009047360A9 Il-21 antibodies
05/06/2010WO2009013543A3 Targeted binging agents directed to kdr and uses thereof - 035
05/06/2010US20100115639 Antibodies inhibiting c-met dimerization and uses thereof
05/06/2010US20100115638 Method for inhibiting the expression of endogenous erythropoietin (epo)
05/06/2010US20100113861 Metallic nanoparticles with coated shells and applications of same
05/06/2010US20100113753 Methods for preparing T-cells for cell therapy
05/06/2010US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same
05/06/2010US20100113361 Anti-ige vaccines
05/06/2010US20100113349 Extracellular matrix-binding proteins from staphylococcus aureus
05/06/2010US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
05/06/2010US20100113303 Polypeptide Display Libraries and Methods of Making and Using Thereof
05/06/2010US20100112078 Polymer particles based vaccine
05/06/2010US20100112077 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
05/06/2010US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
05/06/2010US20100112070 Composition and dosage form comprising a particle formulation and suspending vehicle
05/06/2010US20100112012 Modulation of immune responses
05/06/2010US20100112011 Photodynamic therapy-generated mesothelioma vaccine
05/06/2010US20100112010 Use of conditional plasmodium strains lacking an essential gene in malaria vaccination
05/06/2010US20100112009 Acellular antibordetella vaccine
05/06/2010US20100112008 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
05/06/2010US20100112007 Tuberculosis vaccine and method of using same
05/06/2010US20100112006 Compositions of activated botulinum holotoxin type B (150 kD)
05/06/2010US20100112005 Compositions of activated botulinum toxin type B
05/06/2010US20100112004 Hypoxia inducible factor inducer and methods for using the same
05/06/2010US20100112003 Bifidobacterium in the treatment of inflammatory disease
05/06/2010US20100112002 Modified Pathogens for Use as Vaccines
05/06/2010US20100112001 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
05/06/2010US20100112000 Non-tumorigenic mdck cell line for propagating viruses
05/06/2010US20100111999 Production of poxviruses with adherent or non adherent avian cell lines
05/06/2010US20100111998 Hiv vaccines based on env of multiple clades of hiv
05/06/2010US20100111997 Multi component vaccine containing clostridial and non-clostridial organisms in a low dose
05/06/2010US20100111996 Papaya Mosaic Virus-Based Vaccines for Influenza
05/06/2010US20100111995 Antigen conjugates and uses thereof
05/06/2010US20100111993 Recombinant vaccines and use thereof
05/06/2010US20100111992 Cytomegalovirus peptides and methods of use thereof
05/06/2010US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
1 ... 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 ... 1823